MedTrace Logo

Venous Thromboembolism in Pregnancy Study

NCT00856076 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2011-10-18

No results posted yet for this study

Summary

The purpose of this study is to investigate clinical, biochemical and genetic risk factors for venous thromboembolism in pregnancy and pregnancy related vascular complications, and the long-term outcome of such complications including implications for quality of life.

Conditions

  • Venous Thromboembolism
  • Intrauterine Fetal Death

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Per Morten Sandset, MD, PhD · Oslo University Hospital Ullevål and University of Oslo

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2010-12-31
Completion
2023-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00856076 on ClinicalTrials.gov